Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Zili Hu"'
Autor:
Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-20 (2024)
Abstract Peritumoral hepatocytes are critical components of the liver cancer microenvironment, However, the role of peritumoral hepatocytes in the local tumor immune interface and the underlying molecular mechanisms have not been elucidated. YTHDF2,
Externí odkaz:
https://doaj.org/article/d42c5b5d80614a50a8cc3c82239ec815
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-5 (2023)
Abstract Researches had proven that the occurrence of bladder cancer (BC) is much higher in men than those in women, which induced us to explore whether androgen plays a role in BC. A total of 147 patients who were diagnosed with primary BC by histop
Externí odkaz:
https://doaj.org/article/037ab02dbc914570962280129ecbd895
Autor:
Yizhen Fu, Zhenyun Yang, Zili Hu, Zhoutian Yang, Jinbin Chen, Juncheng Wang, Zhongguo Zhou, Li Xu, Minshan Chen, Yaojun Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach fo
Externí odkaz:
https://doaj.org/article/59b14477458e430f8b5d1fbd85b95722
Autor:
Zili Hu, Zhenyun Yang, Jiongliang Wang, Yizhen Fu, Zhiwen Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background/purpose: The prognosis of hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) is generally poor and hepatectomy is optional for these patients. This study aims to explore the survival benefits of neoadjuvant hepa
Externí odkaz:
https://doaj.org/article/cf710ee031d1411baea8262afaaec3af
Autor:
Zhenyun Yang, Yizhen Fu, Weijie Wu, Zili Hu, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Systemic chemotherapy (SC) remains the only first-line treatment for unresectable intrahepatic cholangiocarcinoma (iCCA). Hepatic arterial infusion chemotherapy (HAIC) has been recently proven to be effective in managing hepatocellular ca
Externí odkaz:
https://doaj.org/article/1844465d45384ba49363c032889fd67a
Autor:
Zili Hu, Zhenyun Yang, Yangxun Pan, Yizhen Fu, Jiongliang Wang, Zhongguo Zhou, Minshan Chen, Dandan Hu, Yaojun Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Hepatic arterial infusion chemotherapy (HAIC) with cisplatin, fluorouracil, and leucovorin (FOLFOX) demonstrated promising efficacy against advanced hepatocellular carcinoma (HCC) as an alleviative treatment. We aimed to explore the survi
Externí odkaz:
https://doaj.org/article/38d3cb8e7a9641ac8f57ba33915b48aa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract To predict disease outcome in muscle-invasive bladder cancer (MIBC), we constructed a prognostic autophagy-related (PAR) lncRNA signature. Comprehensive bioinformatics analyses were performed using data from TCGA and GTEx databases. Univaria
Externí odkaz:
https://doaj.org/article/513374ceae054b9fb4562b5019775472
Autor:
Yongjiang Li, Yangxun Pan, Ximeng Lin, Jingyu Hou, Zili Hu, Li Xu, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Dandan Hu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Background: There is not yet an effective marker in predicting the efficacy of immune checkpoint inhibitors (ICIs) in treating hepatocellular carcinoma (HCC) patients. The Gustave Roussy Immune Score (GRIm-Score) based on three objective variables, n
Externí odkaz:
https://doaj.org/article/611c25bee2e9420d92eed1503b248250
Autor:
Zili Hu, Huilan Zeng, Jingyu Hou, Juncheng Wang, Li Xu, Yaojun Zhang, Minshan Chen, Zhongguo Zhou
Publikováno v:
Viruses, Vol 14, Iss 4, p 656 (2022)
For patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) treated with curative radiofrequency ablation (RFA), the effect of entecavir (ETV) vs. tenofovir disoproxil fumarate (TDF) on recurrence-free survival (RFS) and overall
Externí odkaz:
https://doaj.org/article/893ac7156bb847e98b1e40951d280bc4
Autor:
Weili Zhang, Hu Du, Yunfeng He, Zhikang Yin, Zili Hu, Chunli Luo, Xiaohou Wu, Chuan Liu, Qing Jiang, Yanjun Lin
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 29, Iss 1, p 63 (2010)
Abstract Background and Aim in recent years, Livin, a new member of IAPs family, is found to be a key molecule in cancers. Researchers consider Livin may become a new target for tumor therapy; however, the role of it in bladder cancer is still unclea
Externí odkaz:
https://doaj.org/article/704300feda4f4e64b850d6af42cbd717